Amgen Inc. has acquired cancer drug developer Dark Blue Therapeutics Ltd. in a deal worth as much as $840 million, expanding ...
Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.
Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback